Molecular characterization of occult hepatitis B virus in genotype E-infected subjects

Journal of General Virology

Volumn 89, Issue 2, 2008, Pages 409-418

  Zahn, Astrid ^a   Li, Chengyao ^b,d   Danso, Kwabena ^c   Candotti, Daniel ^b   Owusu Ofori, Shirley ^c   Temple, Jillian ^a   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; HEPATITIS B ANTIBODY;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GHANA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS E; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SERODIAGNOSIS; VIROGENESIS; VIRUS CARRIER; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS LOAD; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE; BLOOD; DISEASE TRANSMISSION; GENETICS; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NEWBORN; PHYLOGENY; VIROLOGY;

HEPATITIS B VIRUS; MIRIDAE;

CARRIER STATE; DNA, VIRAL; FEMALE; GENOTYPE; GHANA; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; PHYLOGENY; VIRAL LOAD;

EID: 41649108518     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83347-0     Document Type: Article

References (42)

1. Allain, J.-P. (2004). Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86, 83-91.
2. Allain, J.-P, Candotti, D., Soldan, K., Sarkodia, F., Phelps, B., Giachetti, C., Shyamala, V., Yeboah, F., Anokwa, M. & other authors (2003). The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101, 2419-2425.
3. Bock, C. T., Malek, N. P., Tillmann, H. L., Manns, M. P. & Trautwein, C. (2000). The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 74, 2193-2202.
4. Brojer, E., Grabarczyk, P., Liszewski, G., Mikulska, M., Allain, J.-P. & Letowska, M. (2006). Characterization of HBV DNA positive/HBsAg negative blood donors identified in the Polish NAT screening program. Hepatology 44, 1666-1674.
5. Candotti, D., Opare-Sem, O., Rezvan, H., Sarkodie, F. & Allain, J.-P. (2006). Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine amino transferase. J Viral Hepat 13, 715-724.
6. Carman, W. F., Boner, W., Fattowich, G., Colman, K., Dornan, E S., Thursz, M. & Hadziyannis, S. (1997). Hepatitis B virus core protein mutations are concentrated in B-cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. J Infect Dis 175, 1093-1100.
7. Chaudhuri, V., Tayal, R., Nayak, B., Acharya, S. K. & Panda, S. K. (2004). Occult hepatitis B virus infection in chronic liver disease: full-length genome analysis of mutant surface promoter. Gastroenterology 127, 1356-1371.
8. Chen, M., Hieng, S., Qian, X., Costa, R. & Ou, J. H. (1994). Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3. Virology 205, 127-132.
9. Erhardt, A., Reineke, U., Blondin, D., Gerlich, W. H., Adams, O., Heintges, T., Niederau, C. & Haussinger, D. (2000).Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31, 716-725.
10. Fujiwara, K., Tanaka, Y., Orito, E., Ohno, T., Kato, T., Sugihara, K., Hasegawa, I., Sakurai, M., Ito, K. & other authors (2005). Distribution of HBV genotypes among HBV carriers in Benin: phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol 11, 6410-6415.
11. Fukai, K., Takada, S., Yokosuka, O., Saisho, H., Omate, M. & Koike, K. (1997). Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell. Virology 236, 279-287.
12. Günther, S., Piwon, N., Jung, A., Iwanska, A., Schmitz, H. & Will, H. (2000). Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 273, 286-299.
13. Ha-Lee, Y. M., Lee, J., Pyun, H., Kim, Y., Sohn, J., Cho, Y. J. & Kim, Y. (2001). Sequence variations of hepatitis B promoter regions in persistently infected patients. Arch Virol 146, 279-292.
14. Hatton, T., Zhou, S. & Standring, D. N. (1992). RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 66, 5232-5241.
15. Huy, T. T., Ishikawa, K., Ampofo, W., Izumi, T., Nakajima, A., Ansah, J., Tetteh, J. O., Nii-Trebi, N., Aidoo, S. & other authors (2006). Characteristics of hepatitis B virus in Ghana: full length genome sequences indicate the endemicity of genotype E in West Africa. J Med Virol 78, 178-184.
16. Jeantet, D., Chemin, I., Mandrand, B., Zoulim, F., Trepo, C. & Kay, A. (2002). Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35, 1215-1224.
17. Kramvis, A. & Kew, M. C. (1999). The core promoter of hepatitis B virus. J Viral Hepat 6, 415-427.
18. Kremsdorf, D., Garreau, F., Duclos, H., Thiers, V., Schellekens, H., Petit, M. A. & Brechot, C. (1993). Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol 18, 244-250.
19. Liao, W. & Ou, J. H. (1995). Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J Virol 69, 1025-1029.
20. Lu, C. C. & Yen, T. S. (1996). Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. Virology 225, 387-394.
21. Mirny, L. A. & Shakhnovich, E. I. (1999). Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. J Mol Biol 291, 177-196.
22. Moolla, N., Kew, M. & Arbuthnot, P. (2002). Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9, 323-331.
23. Mulders, M. N., Venard, V., Njayou, M., Edorth, A. P., Bola Oyefolu, A. O., Kehinde, M. O., Muyembe Tamfun, J. J., Nebie, Y. K., Maiga, I. & other authors (2004). Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190, 400-408.
24. Nassal, M. (1992). The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66, 4107-4116.
25. Neurath, A. R., Kent, S. B., Strick, N. & Parker, K. (1986). Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.
26. Osiowy, C., Giles, E., Tanaka, Y., Mizokami, M. & Minuk, G. Y. (2006). Molecular evolution of hepatitis B virus over 25 years. J Virol 80, 10307-10314.
27. Owusu-Ofori, S., Temple, J., Sarkodie, F., Candotti, D. & Allain, J.-P. (2005). Predonation testing of blood donors in resource-restricted settings. Transfusion 45, 1542-1543.
28. Petit, M. A., Dubanchet, S., Capel, F., Voet, P., Dauguet, C. & Hauser, P. (1991). HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology 180, 483-491.
29. Poch, O., Sauvaget, I., Delarue, M. & Tordo, N. (1989). Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 8, 3867-3874.
30. Pontisso, P., Ruvoletto, M. G., Gerlich, W. H., Heermann, K. H., Bardini, R. & Alberti, A. (1989). Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 173, 522-530.
31. Preisler-Adams, S., Schlayer, H. J., Peters, T., Hettler, F., Gerok, W. & Rasenack, J. (1993). Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 133, 385-396.
32. Radziwill, G., Tucker, W. & Schaller, H. (1990). Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64, 613-620.
33. Raney, A. K., Le, H. B. & McLachlan, A., (1992). Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 66, 6912-6921.
34. Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. (1996). The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2, 1104-1108.
35. Roseman, A. M., Berriman, J. A., Wynne, S. A., Butler, P. J. & Crowther, R. A. (2005). A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci U S A 102, 15821-15826.
36. Schories, M., Peters, T. & Rasenack J. (2000). Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 33, 799-811.
37. Shaul, Y., Ben-Levy, R. & De-Medina, T. (1986). High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. EMBO J 5, 1967-1971.
38. Swofford, D. L. & Sullivan, J. (2003). Phylogenetic inference based on parsimony and other methods using PAUP*. In The Phylogenetic Handbook: A Practical Approach to DNA and Protein Phylogeny, pp. 160-196. Edited by M. Salemi & A.-M. Vandamme. Cambridge: Cambridge University Press.
39. Uchida, T., Shimojima, S., Gotoh, K., Shikata, T. & Mima, S. (1994). Pathology of livers infected with "silent" hepatitis B virus mutant. Liver 14, 251-256.
40. Uchida, T., Gotoh, K. & Shikata, T. (1995). Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B. J Med Virol 45, 247-252.
41. Weinberger, K. M., Wiedenmann, E., Bohm, S. & Jilg, W. (2000). Sensitive and accurate quantitation of hepatitis B virus DNA using kinetic fluorescence detection system (TaqMan PCR). J Virol Methods 85, 75-82.
42. Yotsuyanagi, H., Yasuda, K., Lino, S., Moriya, K., Shintani, Y., Fujie, H., Tsutsumi, T., Kimura, S. & Koike, K. (1998). Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27, 1377-1382.